Adjuvant chemotherapy in lung cancer.Review and prospects
- 1 April 1977
- Vol. 39 (4) , 1415-1424
- https://doi.org/10.1002/1097-0142(197704)39:4<1415::aid-cncr2820390410>3.0.co;2-o
Abstract
The results of trials testing combined surgery and chemotherapy in lung cancer are reviewed. Fifteen adjuvant trials using various chemotherapeutic agents were analyzed to determine reasons for their lack of success. Current trials with adjuvant therapy in lung cancer are briefly outlined. In addition, analysis of the activity of chemotherapeutic agents in advanced lung cancer and its implications in the design of future adjuvant studies are detailed.This publication has 38 references indexed in Scilit:
- Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma.BMJ, 1975
- Current and Future Concepts of Lung CancerAnnals of Internal Medicine, 1975
- L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast CancerNew England Journal of Medicine, 1975
- Use of BCG as an immunostimulant in the surgical treatment of carcinoma of the lungThorax, 1974
- Treatment of Primary Malignant "Coin Lesions" of the LungSurgical Clinics of North America, 1974
- Perspectives in immunotherapy of lung cancerCancer Treatment Reviews, 1974
- Alkylating agents in bronchogenic carcinomaThe American Journal of Medicine, 1969
- Abdominal Exploration in One-Hundred Lung Carcinoma Suspects Prior to ThoracotomyAnnals of Surgery, 1968
- A controlled trial of vinblastine sulphate in the treatment of cancer of the lungRespiratory Medicine, 1966
- Combined surgery and chemotherapy in the treatment of malignant tumorsCancer, 1961